Physiological and QoL Benefits of Qi-Gong in Post-acute Sequelae of Covid-19

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-100
SponsorPOCHIWU

About this trial

The goal of this clinical trial is to determine whether Qi-Gong can improve physiological function and quality of life (QoL) in individuals with post-acute sequelae of SARS-CoV-2 infection (PASC).

Study Objectives:

To assess whether Qi-Gong improves physiological function in individuals with PASC.

To evaluate whether Qi-Gong enhances quality of life in individuals with PASC.

Study Design:

If a comparison group is included, researchers will compare Qi-Gong with standard care to assess its effectiveness.

Participant Involvement:

Practice Qi-Gong three times per week for three months. Record physiological data monthly.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

PASC

above 20 y/o

Disqualifiers

Those who cannot cooperate

Severe schizophrenia

Trial design

Design model

Crossover

Treatments tested in this trial

  • QI-GONG and control

    Behavioral

    QIGONG

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: Qi-Gong GroupExperimental treatment 1 intervention
Group B: routine care GroupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Pulmonary Function Test (Forced vital capacity)

FVC,over 80% is better

Time frame
From enrollment to the end of treatment at 12 weeks
2

Pulmonary Function Test (FEV1)

FEV1,over 80% is better

Time frame
From enrollment to the end of treatment at 12 weeks
3

Pulmonary Function Test (FVCFEV1)

FVCFEV1,over 80% is better

Time frame
From enrollment to the end of treatment at 12 weeks
4

Heart rate variability

Low Frequency,40%-60%

Time frame
From enrollment to the end of treatment at 12 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

POCHIWU

Lead sponsor

National Taipei University of Nursing and Health Sciences

Sponsor institution